Enrollment Info Updated on Phase 3 Trial Assessing AeroVanc for MRSA Infection in CF
Feb 08, 2019 07:00 am | Vijaya Iyer
Enrollment for a Phase 3 clinical trial testing AeroVanc in patients with cystic fibrosis with methicillin-resistant Staphylococcus aureus (MRSA) lung infections is expected to be completed in the third quarter of this year — between July and September. AeroVanc is an inhaled formulation of the antibiotic vancomycin hydrochloride being developed by Savara Pharmaceuticals for difficult-to-treat MRSA infections. These infections […]
The post Enrollment Info Updated on Phase 3 Trial Assessing AeroVanc for MRSA Infection in CF appeared first on Cystic Fibrosis News Today. |
|
Medical Marijuana ‘Can Help Everyone,’ Says Director at Maryland Cannabis Facility
Feb 07, 2019 09:30 am | Larry Luxner
Warning the reporter accompanying him not to take any pictures, veteran horticulturalist Michael Castleman punches an electronic code and unlocks the door to Room 209, nicknamed the “Mother Room.” Photography is indeed forbidden inside this living vault, which contains 20 phenotypes of cannabis plants thriving under the glare of 25 ceramic metal halide lamps for […]
The post Medical Marijuana ‘Can Help Everyone,’ Says Director at Maryland Cannabis Facilityappeared first on Cystic Fibrosis News Today. |
|
Research Partners Work to Simplify, Improve Assessment of Lungs for Transplant
Feb 07, 2019 07:00 am | Santiago Gisler
SQI Diagnostics announced two new research agreements with research hospital University Health Network (UHN), Toronto, Canada, to simplify the assessment of lungs for transplant. By creating and licensing multiplexed protein assays and point-of-care diagnostic strategies, they intend to improve the health of donor organs so they can be transplanted safely to end-stage lung disease patients, including cystic […]
The post Research Partners Work to Simplify, Improve Assessment of Lungs for Transplantappeared first on Cystic Fibrosis News Today. |
|
|
No hay comentarios:
Publicar un comentario